Protective Effects of Engineered <i>Lactobacillus crispatus</i> on Intrauterine Adhesions in Mice <i>via</i> Delivering CXCL12.

Front Immunol · 2022 · PMC9207254 · PMID 35734171

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

2.89, P < 0.05) showed an increasing trend compared with the control group, whereas treatment with L. crispatus and L. crispatus -pMG36e-mCXCL12 reversed this trend and restored the expression levels of TGF-β1, p−Smad2 and p−Smad3 in the NDT group to 4.62, 3.18 and 1.69 and in the EDT group to 3.52, 1.55 and 1.27, respectively.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Protective Effects of Engineered &lt;i&gt;Lactobacillus crispatus&lt;/i&gt; on Intrauterine Adhesions in Mice &lt;i&gt;via&lt;/i&gt; Delivering CXCL12.

The sentences

Protective Effects of Engineered <i>Lactobacillus crispatus</i> on Intrauterine Adhesions in Mice <i>via</i> Delivering CXCL12.